A. Ucar Et Al. , "Effects of chronic treatment with indomethacin at clinically relevant doses on intestinal tissue 6-keto prostaglandin F-1 alpha and leukotriene B-4 level in relation to gastroenteropathy," INFLAMMATION , vol.22, no.3, pp.243-252, 1998
Ucar, A. Et Al. 1998. Effects of chronic treatment with indomethacin at clinically relevant doses on intestinal tissue 6-keto prostaglandin F-1 alpha and leukotriene B-4 level in relation to gastroenteropathy. INFLAMMATION , vol.22, no.3 , 243-252.
Ucar, A., SAK, S., & Melli, M., (1998). Effects of chronic treatment with indomethacin at clinically relevant doses on intestinal tissue 6-keto prostaglandin F-1 alpha and leukotriene B-4 level in relation to gastroenteropathy. INFLAMMATION , vol.22, no.3, 243-252.
Ucar, A, SERPİL SAK, And M Melli. "Effects of chronic treatment with indomethacin at clinically relevant doses on intestinal tissue 6-keto prostaglandin F-1 alpha and leukotriene B-4 level in relation to gastroenteropathy," INFLAMMATION , vol.22, no.3, 243-252, 1998
Ucar, A Et Al. "Effects of chronic treatment with indomethacin at clinically relevant doses on intestinal tissue 6-keto prostaglandin F-1 alpha and leukotriene B-4 level in relation to gastroenteropathy." INFLAMMATION , vol.22, no.3, pp.243-252, 1998
Ucar, A. SAK, S. And Melli, M. (1998) . "Effects of chronic treatment with indomethacin at clinically relevant doses on intestinal tissue 6-keto prostaglandin F-1 alpha and leukotriene B-4 level in relation to gastroenteropathy." INFLAMMATION , vol.22, no.3, pp.243-252.
@article{article, author={A Ucar Et Al. }, title={Effects of chronic treatment with indomethacin at clinically relevant doses on intestinal tissue 6-keto prostaglandin F-1 alpha and leukotriene B-4 level in relation to gastroenteropathy}, journal={INFLAMMATION}, year=1998, pages={243-252} }